Viewing Study NCT01585766


Ignite Creation Date: 2025-12-24 @ 4:26 PM
Ignite Modification Date: 2026-05-19 @ 9:00 AM
Study NCT ID: NCT01585766
Status: COMPLETED
Last Update Posted: 2018-10-29
First Post: 2012-04-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis
Sponsor: MedImmune LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis, Relapsing Forms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MAb, B cell, depletion, RMS View